March 15 (Reuters) - Rohto Pharmaceutical Co Ltd 4527.T
* Says it signed license agreement with Japan Tobacco Inc
2914.T , regarding the exclusive rights to develop and
commercialize JTE-052, which is used for disease treatment in
the field of ophthalmology, in Japan
Source text in Japanese:http://bit.ly/2FJzYuC
Further company coverage: 4527.T 2914.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +8601082555111;
Reuters Messaging: Pingping.Li1@thomsonreuters.com@reuters.net))